EMG
EPZM

Ellington Management Group’s Epizyme, Inc EPZM Stock Holding History

Ellington Management Group’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-31,314
Closed -$556K – 948
2018
Q1 		$556K Buy
+31,314
New +$529K 0.04% 377
2017
Q3 		– Sell
-12,400
Closed -$187K – 915
2017
Q2 		$187K Buy
12,400
+1,900
+18% +$28.7K 0.03% 545
2017
Q1 		$180K Buy
+10,500
New +$140K 0.01% 604

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ellington Management Group's EPZM Position: Q2 2018 in Review

Ellington Management Group sold out of Epizyme, Inc (EPZM) in Q2 2018, closing a stake of 31,314 shares — an estimated $556K sold.

Ellington Management Group first reported a position in EPZM in Q1 2017 and held it in 3 quarters. The position peaked at $556K in Q1 2018. 109 funds tracked by Wall St. Rank hold EPZM as of Q2 2018.

  • Ellington Management Group reported no remaining Epizyme, Inc position as of Q2 2018 after selling out during the quarter.
  • Ellington Management Group sold 31,314 Epizyme, Inc shares in Q2 2018, an estimated $556K.
  • Ellington Management Group first reported a position in Epizyme, Inc in Q1 2017 and held it in 3 quarters.
  • Ellington Management Group's Epizyme, Inc position peaked at $556K in Q1 2018.
  • 109 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2018.

Based on Ellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.